Actively Recruiting
Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-01
120
Participants Needed
1
Research Sites
157 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. Assess differences in flow patterns in the fetal cerebral blood vessels within 24 hours before delivery between fetuses with a normal vs. adverse perinatal outcome. 2. Explore maternal and/or fetal characteristics that might influence technical feasibility of doppler sonography of the fetal cerebral blood vessels in early labor at term. 3. Assess reliability of the technique by measuring intra- and inter-observer variation in a subset of participants.
CONDITIONS
Official Title
Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Singleton pregnancy
- Term gestation between 37 and 42 weeks
- Fetus in cephalic (head-down) presentation
- No known fetal chromosomal or severe congenital anomaly
- Normal fetal growth confirmed by ultrasound between 30 and 37 weeks
- No pre-existing Doppler or amniotic fluid abnormalities
- Normal fetal heart rate tracing (CTG) without signs of hypoxia
- Admission in early spontaneous labor or induction of labor with expected delivery within 24 hours
- Maternal age 18 years or older
- Willing to give written informed consent
You will not qualify if you...
- Advanced labor with more than 4 cm cervical dilatation at admission
- Severe chronic maternal medical conditions or poor obstetric history with increased risk of adverse perinatal outcome (such as uncontrolled hypertension, severe pre-eclampsia, uncontrolled diabetes, maternal sepsis, major bleeding, intra-uterine infection, prolonged rupture of membranes over 18 hours)
- Intra-uterine fetal demise or death
- Prelabour rupture of membranes with meconium-stained amniotic fluid
- Patients not meeting all inclusion criteria or refusing to give written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospitals Leuven, department of obstetrics and gynaecology
Leuven, Belgium, 3000
Actively Recruiting
Research Team
B
Bram Packet
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here